B Cell Epitope Mapping of the Bacterial Superantigen Staphylococcal Enterotoxin B: The Dominant Epitope Region Recognized by Intravenous IgG

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 247-254

  Nishi, Jun Ichiro ^a   Kanekura, Shoko ^a   Take, Shuji ^a   Kitajima, Isao ^a   Nakajima, Toshihiro ^a   Wahid, Mohammad Rezwanul ^a   Masuda, Kiminori ^a   Yoshinaga, Masao ^a   Maruyama, Ikuro ^a   Miyata, Koichiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; EPITOPE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; SUPERANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; EPITOPE MAPPING; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; ENTEROTOXINS; EPITOPE MAPPING; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; MOLECULAR SEQUENCE DATA; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 0030639729     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27.
2. Janeway, C. A., J. Yagi, P. J. Conrad, M. E. Katz, B. Jones, S. Vroegop, and S. Buxser. 1989. T cell responses to Mls and to bacterial proteins that mimic its behavior. Immunol. Rev. 107:61.
3. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705.
4. Schlievert, P. M. 1993. Role of superantigens in human disease. J. Infect. Dis. 167:997.
5. Choi, Y., J. A. Lafferty, J. R. Clements, J. K. Todd, E. W. Gelfand, J. Kappler, P. Marrack, and B. L. Kotzin. 1990. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 172:981.
6. Abe, J., B. L. Kotzin, K. Jujo, M. E. Melish, M. P. Glode, T. Kohsaka, and D. Y. M. Leung. 1992. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc. Natl. Acad. Sci. USA 89:4066.
7. Abe, J., B. L. Kotzin, C. Meissner, M. E. Melish, M. Takahashi, D. Fulton, F. Romagne, B. Malissen, and D. Y. M. Leung. 1993. Characterization of T cell repertoire changes in acute Kawasaki disease. J. Exp. Med. 177:791.
8. Curtis, N., R. Zhene, J. R. Lamb, and M. Levin. 1995. Evidence for a superantigen mediated process in Kawasaki disease. Arch. Dis. Child. 72:308.
9. Pietra, B. A., J. D. Inocencio, E. H. Giannini, and R. Hirsch. 1994. TCR Vβ family repertoire and T cell activation markers in Kawasaki disease. J. Immunol. 153:1881.
10. Watanabe-Ohnishi, R., D. E. Low, A. McGeer, D. L. Stevens, P. M. Schilievert, D. Newton, B. Schwartz, B. Kreiswirth, Ontario Streptococcal Study Project, and M. Kotb. 1995. Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J. Infect. Dis. 171:74.
11. Miyoshi-Akiyama, T., K. Imanishi, and T. Uchiyama. 1993. Purification and partial characterization of a product from Yersinia pseudotuberculosis with ability to activate human T cells. Infect. Immun. 61:3922.
12. Uchiyama, T., T. Miyoshi-Akiyama, H. Kato, W. Fujimaki, K. Imanishi, and X. J. Yan. 1993. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis manifesting acute and systemic symptoms. J. Immunol. 151:4407.
13. Abe, J., T. Takeda, Y. Watanabe, H. Nakao, N. Kobayashi, D. Leung, and T. Kohsaka. 1993. Evidence for superantigen production by Yersinia pseudotuberculosis. J. Immunol. 151:4183.
14. Abe, Y., S. Nakano, T. Nakahara, Y. Kamezawa, I. Kato, H. Ushijima, K. Yoshino, S. Ito, S. Noma, S. Okitsu, and M. Tajima. 1990. Detection of serum antibody by the antimitogen assay against streptococcal erythrogenic toxins: age distribution in children and the relation to Kawasaki disease. Pediatr. Res. 27:11.
15. Takei, S., Y. K. Arora, and S. M. Walker. 1993. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin. Invest. 91:602.
16. Kuwahata, M., H. Imanaka, S. Takei, and K. Masuda. 1996. Age-related occurrence of inhibitory antibodies to streptococcal pyrogenic superantigens. Acta Paediatr. Jpn. 38:1.
17. Kappler, J. W., A. Herman, J. Clements, and P. Marrack. 1992. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J. Exp. Med. 175:387.
18. Swaminathan, S., W. Furey, J. Pletcher, and M. Sax. 1992. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801.
19. Hayball, J. D., J. H. Robinson, R. E. O'Hehir, A. Verhoef, J. R. Lamb, and R. A. Lake. 1993. Identification of two binding sites in staphylococcal enterotoxin B that confer specificity for TCR Vβ gene products. Int. Immunol. 6:199.
20. Hamad, A. R. A., A. Herman, P. Marrack, and J. W. Kappler. 1994. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B. J. Exp. Med. 180:615.
21. Jardetzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, Y. Chi, C. Stauffacher, J. L. Strominger, and D. C. Wiley. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711.
22. Casman, E. P., M. S. Bergdoll, and J. Robinson. 1963. Designation of staphylococcal enterotoxins. J. Bacteriol. 85:715.
23. Jones, C. L., and S. A. Khan. 1986. Nucleotide sequence of the enterotoxin B gene from Staphylococcus aureus. J. Bacteriol. 166:29.
24. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51.
25. Hudson, K. R., H. Robinson, and J. D. Fraser. 1993. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor Vβ specificity. J. Exp. Med. 177:175.
26. Mollick, J. A., R. L. McMasters, D. Grossman, and R. Rich. 1993. Localization of a site on bacterial superantigens that determines T cell receptor β chain specificity. J. Exp. Med. 177:283.
27. Walker, S. M., B. Shaham, D. K. McCurdy, H. Wietting, Y. K. Arora, V. Hanson, and B. H. Bernstein. 1990. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA. J. Rheumatol. 17:936.
28. Pettersson, I. 1992. Methods of epitope mapping. Mol. Biol. Rep. 16:149.
29. Kohsaka, H., K. Yamamoto, H. Fujii, H. Miura, N. Miyasaka, K. Nishioka, and T. Miyamoto. 1990. Fine epitope mapping of the human SS-B/La protein: identification of a distinct autoepitope homologous to a viral gag polyprotein. J. Clin. Invest. 85:1566.
30. Misaki, Y., K. Yamamoto, K. Yanagi, H. Miura, H. Ichijo, T. Kato, T. Mato, S. W. Wester, K. Nishioka, and K. Ito 1993. B cell epitope on the U1 snRNP-C autoantigen contains a sequence similar to that of the herpes simplex virus protein. Eur. J. Immunol. 23:1064.
31. Ansari, A. A., N. Neckelmann, F. Villinger, P. Leung, D. J. Danner, S. S. Brar, S. Zhao, M. B. Gravanis, A. Mayne, M. E. Gershwin, and A. Herskowitz. 1994. Epitope mapping of the branched chain α-ketoacid dehydrogenase dihydrolipoyl transacylase (BCKD-E2) protein that reacts with sera from patients with idiopathic dilated cardiomyopathy. J. Immunol. 153:4754.
32. Tseno, J., J. L. Komisar, R. N. Trout, R. E. Hunt, J. Y. Chen, A. J. Johnson, L. Pitt, and D. L. Ruble. 1995. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres. Infect. Immun. 63:2880.
33. Goldstein, G. 1974. Isolation of bovine thymin: a polypeptide hormone of the thymus. Nature 247:11.
34. Basch, R. S., and G. Goldstein. 1974. Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus. Proc. Natl. Acad. Sci. USA 71:1474.
35. Sunshine, G. H., R. S. Basch, R. G. Coffey, K. W. Cohen, G. Goldstein, and J. W. Hadden. 1978. Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytes. J. Immunol. 120:1594.
36. Audhya, T., D. H. Schlesinger, and G. Goldstein. 1987. Isolation and complete amino acid sequence of human thymopoietin and splenin. Proc. Natl. Acad. Sci. USA 84:3545.
37. Goldstein, G., M. P. Scheid, E. A. Boyse, D. H. Schlesinger, and J. V. Wauwe. 1979. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 204:1309.
38. Kantharia, B. K., N. J. Goulding, N. D. Hall, J. Davies, P. J. Maddison, P. A. Bacon, M. Farr, J. A. Wojtulewski, K. M. Englehart, S. P. Liyanage, and N. L. Cox. 1989. Thymopentin (TP-5) in the treatment of rheumatoid arthritis. Br. J. Rheumatol. 28:118.
39. Leung, D. Y., R. L. Hirsch, L. Schneider, C. Moody, R. Takaoka, S. H. Li, L. A. Meyerson, S. G. Mariam, G. Goldstein, and J. M. Hanifin. 1990. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J. Allergy Clin. Immunol. 85:927.
40. + cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled study. AIDS 6:1335.